Milbank advises invoX Pharma Limited on CFIUS clearance for $161 million acquisition of F-star Therapeutics | The Sponsor - The Sponsor

Deals

Cases

SOON

News

Moves

The Sponsor

Loading page...

Stay informed with the latest news and developments in the legal industry. Explore profiles of top law firms and their talented professionals. Empowering the legal community with real-time insights and comprehensive firm profiles.

Directories

Deals

News

Moves

Firms

Account

Profile

SOON

Sign in

SOON

Analysis

AI Rankings

Deal Activity

Salaries

SOON

Firm Comparison

SOON

© The Sponsor. All rights reserved.

Terms & Conditions | Privacy Policy

$161.00 Million deal in Acquisition

Milbank advises invoX Pharma Limited on CFIUS clearance for $161 million acquisition of F-star Therapeutics

Last Updated: 10 Mar 2023

invoX Pharma Limited advisor

Milbank LLP

Overview

invoX Pharma Limited acted as the acquirer in this Acquisition transaction.
The acquisition targeted assets operating in the Biopharmaceuticals sector.
The transaction was announced on 10 Mar 2023 with a reported value of 1610000000.0.

Generated by AI, original source from - Data is in progress

F-star Therapeutics, Inc. advisor

Firm name is in progress

Found it useful? Spread the word.